Oral nitrates are used in the treatment of angina and congestive heart
failure. In 1993, more than 12 million prescriptions for chronic admi
nistration of oral nitrates were written in the United States. Three n
itrate compounds are currently available on the U.S. market: nitroglyc
erin, isosorbide dinitrate and the most recent, isosorbide mononitrate
. Oral nitrates are available in sublingual, translingual (spray), tra
nsmucosal, chewable or sustained-release forms. Despite the complexity
of choices, therapy can be simplified and remain efficacious, provide
d that attention is given to circumventing tolerance, a challenging pr
oblem with nitrate therapy. Tolerance can be avoided by ensuring that
there is a daily nitrate-free interval using eccentric (i.e., 8 A.M. a
nd 2 P.M.), twice-daily dosing of standard or sustained-release forms,
or frequent intermittent low dosages.